相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD40 Agonist Antibodies in Cancer Immunotherapy
Robert H. Vonderheide
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration
David Kolb et al.
ACS NANO (2020)
Tuning the InVivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles
Chuanqi Peng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma
Peng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Anna Galstyan et al.
NATURE COMMUNICATIONS (2019)
Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
Xiang Ling et al.
ACS NANO (2019)
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Jodi L. Karnell et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Nanomedicines Lost in Translation
Keegan Guidolin et al.
ACS NANO (2019)
Erythroliposomes: Integrated Hybrid Nanovesicles Composed of Erythrocyte Membranes and Artificial Lipid Membranes for Pore-Forming Toxin Clearance
Yuwei He et al.
ACS NANO (2019)
Advancing Cancer Immunotherapies with Nanotechnology
Jenny Lou et al.
ADVANCED THERAPEUTICS (2019)
Application and design of esterase-responsive nanoparticles for cancer therapy
Haonan Dong et al.
DRUG DELIVERY (2019)
Tailoring Platinum(IV) Amphiphiles for Self-Targeting All-in-One Assemblies as Precise Multimodal Theranostic Nanomedicine
Shasha He et al.
ACS NANO (2018)
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Kabir A. Khan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
Quanyin Hu et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Bioresponsive materials
Yue Lu et al.
NATURE REVIEWS MATERIALS (2017)
New Insights into the Role of Matrix Metalloproteinases in Preeclampsia
Salvador Espino Y Sosa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R. Ramjiawan et al.
ANGIOGENESIS (2017)
IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma
Kristen B. Long et al.
CANCER DISCOVERY (2016)
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
Katelyn T. Byrne et al.
CELL REPORTS (2016)
Anti-Metastatic and Anti-Angiogenic Activities of Core-Shell SiO2@LDH Loaded with Etoposide in Non-Small Cell Lung Cancer
Yanjing Zhu et al.
ADVANCED SCIENCE (2016)
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
A. K. Nowak et al.
ANNALS OF ONCOLOGY (2015)
Podophyllotoxin derivatives: a patent review (2012-2014)
Ahmed Kamal et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang et al.
CANCER RESEARCH (2013)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
Robert H. Vonderheide et al.
ONCOIMMUNOLOGY (2013)
Differentiating malignant colorectal tumor patients from benign colorectal tumor patients by assaying morning urinary arylsulfatase activity
Rungui Niu et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2012)
Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis et al.
NATURE MEDICINE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Inhibition of tumor angiogenesis by oral etoposide
Dipak Panigrahy et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2010)
A Review on Hemisynthesis, Biosynthesis, Biological Activities, Mode of Action, and Structure-Activity Relationship of Podophyllotoxins: 2003-2007
Hui Xu et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development
Anna Kruczynski et al.
EUROPEAN JOURNAL OF CANCER (2006)
Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis
Ho-Jin Park et al.
STEM CELL REVIEWS (2006)
Angiogenesis: from plants to blood vessels
Tai-Ping Fan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling
L Vincent et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Efficacy of ifosfamide and etoposide in patients with small cell lung cancer and the influence of angiogenesis on chemosensitivity
H Liu et al.
LUNG CANCER (2005)
Glutathione metabolism and its implications for health
GY Wu et al.
JOURNAL OF NUTRITION (2004)
Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly
JY Wang et al.
ANTI-CANCER DRUGS (2003)
分享论文
